Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children
NCT02765217Phase 4Completed
- Sponsor
- Eskişehir Osmangazi University
- Start
- Jun 2017
- Primary completion
- Jul 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Lactobacillus reuteri DSM 17938 in antibiotic-associated diarrhea (AAD), sponsored by Eskişehir Osmangazi University. Started Jun 2017; status: completed.
02
Drugs
Lactobacillus reuteri DSM 17938
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on NCT02765217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765217.